首页 | 本学科首页   官方微博 | 高级检索  
     

抵抗素在肝脏胰岛素抵抗中的作用及其机制探讨
引用本文:李焱,何娟,李芳萍,刘珊英,罗招凡,黎峰,刘丹,徐明彤,严励. 抵抗素在肝脏胰岛素抵抗中的作用及其机制探讨[J]. 中国药理学通报, 2009, 25(2)
作者姓名:李焱  何娟  李芳萍  刘珊英  罗招凡  黎峰  刘丹  徐明彤  严励
作者单位:1. 中山大学附属第二医院内分泌科,广东,广州,510120
2. 贵阳医学院附属医院内分泌科,贵州,贵阳,550004
基金项目:国家自然科学基金,广东省自然科学基金,教育部回国人员科研启动项目 
摘    要:目的探讨抵抗素在肝脏胰岛素抵抗中的作用及其可能的机制。方法将载有抵抗素基因的重组腺病毒经尾静脉注射构建高抵抗素血症小鼠模型,同时设正常对照组及病毒对照组,取肝脏组织切片行PAS糖原染色半定量观察肝糖代谢变化;以Western blot检测肝腺苷酸活化蛋白激酶(AMPK)的磷酸化,以磷酸化AMPK/总AMPK的比值代表AMPK激活程度;以实时PCR检测肝组织糖异生关键酶葡萄糖6磷酸酶(G6Pase)和磷酸烯醇式丙酮酸羧激酶(PEP-CK)mRNA表达水平的变化。结果重组腺病毒注射d5获得血中抵抗素高表达构建了高抵抗素血症动物模型,糖原染色示高抵抗素血症小鼠肝糖原含量较正常对照及病毒对照组降低(P<0.05);高抵抗素血症组肝AMPK磷酸化水平较正常对照及病毒对照组下降,磷酸化AMPK/总AMPK比值分别为0.78±0.06vs0.93±0.13,0.89±0.05(P<0.05)。高抵抗素血症小鼠G6Pase和PEPCK的mRNA表达升高,G6Pase分别为2.136±0.857vs1.353±0.49,1.250±0.77;PEPCK分别为3.54±0.90vs2.75±0.78,2.63±0.67(P<0.05)。结论抵抗素可能通过抑制肝脏AMPK活性,增加肝糖异生关键酶的表达而影响机体肝糖代谢,降低肝糖储量,参与肝脏胰岛素抵抗的形成。

关 键 词:抵抗素  肝脏胰岛素抵抗  肝糖原  AMP激活蛋白激酶  磷酸烯醇式丙酮酸羧激酶  葡萄糖6磷酸酶

The role of resistin in hepatic insulin resistance and the underlying mechanism
LI Yan,HE Juan,LI Fang-ping,LIU Shan-ying,LUO Zhao-fan,LI Feng,LIU Dan,XU Ming-tong,YAN Li. The role of resistin in hepatic insulin resistance and the underlying mechanism[J]. Chinese Pharmacological Bulletin, 2009, 25(2)
Authors:LI Yan  HE Juan  LI Fang-ping  LIU Shan-ying  LUO Zhao-fan  LI Feng  LIU Dan  XU Ming-tong  YAN Li
Abstract:Aim To investigate the role of resistin in hepatic insulin resistance and its mechanism.Methods We established a mouse model of hyperresistinemia in C57BL/6 mice by intravenous administration of the recombinant adenovirus encoding mouse resistin.Using periodic acid-Schiff staining we observed the effects of resistin on the hepatic glycogen storage.Western blot was used to measure AMPK-protein and phosphrylated AMPK-(Thr172) protein.mRNA level of phosphoenolpyruvate carboxykinase gene and glucose-6-phosphatase gene was measured by real-time PCR.Results On the fifth day after Adv injection,the concentration of plasma resistin was much higher in Adv-resistin-EGFP-treated mice than in saline-or Adv-EGFP-treated mice.The semiquantitation of hepatic glucogen storage by PAS showed that the mice with hyperresistinemia had decreased glycogen particles compared with normal control and Adv-EGFP groups.The ratio of phosphorylated AMPK(Thr172)-to total AMPK-was used to evaluate hepatic AMPK activation.Compared with normal control and Adv-EGFP groups,the Adv-resistin-EGFP-treated mice had significantly lower ratio of p-AMPK/AMPK,and higher expression levels of G6Pase and PEPCK mRNA in liver.Conclusion Resistin may decrease AMPK activation with downregulated expression of gluconeogenic enzymes,resulting in increased glucose production and decreased hepatic glycogen storage.Resistin may play an important role in hepatic insulin resistance.
Keywords:resistin  hepatic insulin resistance  hepatic glycogen  AMP-activated protein kinase  phosphoenolpyruvate carboxykinase  glucose-6-phosphatase
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号